Skip to main content
. 2019 Jul 2;39(7):BSR20181852. doi: 10.1042/BSR20181852

Figure 9. The potential molecular mechanisms that miR-15a-5p could improve diabetic AS by down-regulating FASN levels.

Figure 9

miR-145 inhibits the levels of AS biomarkers through targeting FASN. Diabetic AS is improved with overexpression of miR-15a-5p.